GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,314,826 | -28.3% | 1,666,181 | +4.0% | 0.32% | -32.4% |
| Q2 2023 | $8,809,713 | +27.9% | 1,601,766 | 0.0% | 0.48% | +75.0% |
| Q1 2023 | $6,887,594 | +47.7% | 1,601,766 | +35.0% | 0.27% | +32.0% |
| Q4 2022 | $4,662,139 | -12.0% | 1,186,295 | +18.9% | 0.21% | -37.0% |
| Q3 2022 | $5,299,000 | -68.9% | 997,857 | -61.6% | 0.33% | -66.4% |
| Q2 2022 | $17,040,000 | -10.6% | 2,597,631 | 0.0% | 0.97% | +12.0% |
| Q1 2022 | $19,067,000 | +36.3% | 2,597,631 | +31.5% | 0.87% | +22.0% |
| Q4 2021 | $13,984,000 | -65.1% | 1,975,146 | +23.5% | 0.71% | -63.9% |
| Q3 2021 | $40,106,000 | +5.3% | 1,599,774 | +12.9% | 1.97% | +28.8% |
| Q2 2021 | $38,103,000 | – | 1,416,483 | – | 1.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |